Discuss This Drug

BELATACEPT

CHEBI:CHEBI_753809

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1112980
product_type
BULK INGREDIENT
listing_expiration_date
20241231
active_ingredient_strength
1 kg/kg
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BULK INGREDIENT
labeler_name
Lotte Biologics USA, LLC
manufacturer_name
E.R. Squibb & Sons, L.L.C.
marketing_start_date
20110615
package_marketing_start_date
15-JUN-11
generic_name
BELATACEPT
active_ingredient_name
BELATACEPT
brand_name
NULOJIX
brand_name_base
NULOJIX
product_ndc
83157-0371
application_number
BLA125288
spl_id
018e5bbe-cd54-4037-a169-bc65c8e4712d
package_ndc
83157-0371-9
package_description
10.25 kg in 1 BOTTLE (83157-0371-9)
unii
E3B2GI648A
spl_set_id
c16ac648-d5d2-9f7d-8637-e2328572754e
nui
N0000182151
pharm_class_epc
Selective T Cell Costimulation Blocker [EPC]
pharm_class
CD86-directed Antibody Interactions [MoA]
pharm_class_pe
T Lymphocyte Costimulation Activity Blockade [PE]
pharm_class_moa
CD86-directed Antibody Interactions [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class